Stigma Grow’s Live and Cured Hydrocarbon Concentrates hit the markets with great success.

May 19, 2020

As they continue to grow, Stigma Grow is already producing large quantities of both live resin and cured concentrates for in-house and third-party cannabis brands.

 

Red Deer, May 19, 2020  – CanadaBis Capital Inc. (“CanadaBis” or “the Company”), a vertically integrated Canadian cannabis company focused on finding and capitalizing on growth and diversification opportunities, is pleased to announce that its subsidiary Stigma Grow, has become the first Canadian LP to produce and distribute live resin caviar, live resin badder and cured badder to retailers across Canada.

Stigma Grow's BHO Concentrates

The Company, who anticipated a shift in consumer behaviour from a focus on dry flower to a focus on concentrates in 2020 and beyond, has spent the last year securing the right-fit partnerships, processes and personnel, before securing multiple POs across Canada for their Hydrocarbon high-potency concentrates.

On April 19th, the Company oversaw the shipment of their first 6,000+ packages of Chapter 1: Cured Badder and has since shipped out an additional 14,000 units of Live Res Badder and Live Res Caviar under the brand Premium 5.

“The future of cannabis is strong, and it’s here!”, exclaims Travis McIntyre, President and CEO of Stigma Grow. We’ve spent the last year perfecting our systems and constructing a CIDI Lab to house hydrocarbon extraction processing — positioning us to bring difficult-to-produce products to market on a mass under our brand, and as a third-party processor for other high-quality cannabis growers.

Stigma Grow intends to leverage their top-quality flower, state-of-the-art technology, and the insight provided by their skilled and experienced staff, to maintain their position as recognized Canadian leaders in high-quality, ‘bud-run’ extract product variations.

Travis explains, “Our vision as a company has always been to provide our community with what is in-demand, and all signs point to the need for consistent, high-potency concentrates. The response and momentum we’ve seen over the past few months has positioned our company for the type of growth and influence we’ve always envisioned.”

As of the date of this release, Stigma Grow represents Canada’s first-to-market and leader in BHO cannabis concentrates.

About CanadaBis Capital Inc.

CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.

For more information on CanadaBis Capital, 1998643 (Stigma Grow), or INDICAtive Collection please visit www.canadabis.com, www.stigmagrow.ca, www.indicativecollection.ca or contact:

Investor Relations

Info@CanadaBis.com

1-888-STIGMA1

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to our business and operations including development and expansion plans; intention to develop property in British Columbia; increasing our product lines to include CBD distillates; and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; successful negotiation of necessary agreements to get our product to market; requirement for further capital, delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Filing Statement available on SEDAR at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. CanadaBis Capital does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Back to Press Releases